Common use of Option to Purchase Additional Securities Clause in Contracts

Option to Purchase Additional Securities. (a) For the purposes of covering any over-allotments in connection with the distribution and sale of the Closing Securities, the Representative is hereby granted an option (the “Option”) to purchase, in the aggregate, up to 1,470,000 shares of Common Stock (the “Option Shares”) and Warrants to purchase up to 2,940,000 shares of Common Stock (the “Option Warrants” and, collectively with the Option Shares, the “Option Securities”) which may be purchased in any combination of Option Shares and/or Option Warrants at the Share Purchase Price and/or Warrant Purchase Price, respectively.

Appears in 1 contract

Samples: Underwriting Agreement (Quanergy Systems, Inc.)

AutoNDA by SimpleDocs

Option to Purchase Additional Securities. (a) For the purposes of covering any over-allotments in connection with the distribution and sale of the Closing Securities, the Representative is hereby granted an option (the “Option”) to purchase, in the aggregate, up to 1,470,000 85,430 shares of Common Stock (the “Option Shares”) and Warrants to purchase up to 2,940,000 25,629 shares of Common Stock (the “Option Warrants” and, collectively with the Option Shares, the “Option Securities”) which may be purchased in any combination of Option Shares and/or Option Warrants at the Share Purchase Price and/or Warrant Purchase Price, respectively.

Appears in 1 contract

Samples: Underwriting Agreement (Intelligent Bio Solutions Inc.)

Option to Purchase Additional Securities. (a) For the purposes of covering any over-allotments in connection with the distribution and sale of the Closing Securities, the Representative is hereby granted an option (the “Option”) to purchase, in the aggregate, up to 1,470,000 0 shares of Common Stock (the “Option Shares”) and Warrants Series 1 Warrants, if available, and Series 2 Warrants, as applicable, to purchase up to 2,940,000 4,471,420 shares of Common Stock (the “Option Warrants” and, collectively with the Option Shares, the “Option Securities”) which may be purchased in any combination of Option Shares and/or Option Warrants at the Share Purchase Price and/or Warrant Purchase Price, respectively.

Appears in 1 contract

Samples: Underwriting Agreement (Benitec Biopharma Inc.)

Option to Purchase Additional Securities. (a) For the purposes of covering any over-allotments in connection with the distribution and sale of the Closing Securities, the Representative is hereby granted an option (the “Option”) to purchase, in the aggregate, up to 1,470,000 552,900 shares of Common Stock (the “Option Shares”) and and/or Common Warrants to purchase up to 2,940,000 552,900 shares of Common Stock (the “Option Warrants” and, collectively with the Option Shares, the “Option Securities”) which may be purchased in any combination of Option Shares and/or Option Warrants at the Share Purchase Price and/or Warrant Purchase Price, respectively.

Appears in 1 contract

Samples: Underwriting Agreement (Windtree Therapeutics Inc /De/)

Option to Purchase Additional Securities. (a) For the purposes of covering any over-allotments in connection with the distribution and sale of the Closing Securities, the Representative is hereby granted an option (the “Option”) to purchase, in the aggregate, up to 1,470,000 285,714 shares of Common Stock (the “Option Shares”) and ), Series A Warrants to purchase up to 2,940,000 571,428 shares of Common Stock and/or Series B Warrants to purchase up to 571,428 shares of Common Stock (the “Option Warrants” and, collectively with the Option Shares, the “Option Securities”) which may be purchased in any combination of Option Shares and/or Option Warrants at the Share Purchase Price and/or Warrant Purchase Price, respectively.

Appears in 1 contract

Samples: Underwriting Agreement (Peraso Inc.)

Option to Purchase Additional Securities. (a) For the purposes of covering any over-allotments in connection with the distribution and sale of the Closing Securities, the Representative is hereby granted an option (the “Option”) to purchase, in the aggregate, up to 1,470,000 2,331,606 shares of Common Stock (the “Option Shares”) and Common Warrants to purchase up to 2,940,000 2,331,606 shares of Common Stock (the “Option Warrants”, and, collectively with the Option Shares, the “Option Securities”) which may be purchased in any combination of Option Shares and/or Option Warrants at the Share Purchase Price and/or Warrant Purchase Priceprice, respectively.

Appears in 1 contract

Samples: Underwriting Agreement (Benitec Biopharma Inc.)

Option to Purchase Additional Securities. (a) For the purposes of covering any over-allotments in In connection with the distribution and sale of the Closing Securities, the Representative is hereby granted an option (the “Option”) to purchase, in the aggregate, up to 1,470,000 1,846,153 shares of Common Stock (the “Option Shares”) at the Share Purchase Price and/or and Series C Warrants to purchase up to 2,940,000 1,846,153 shares of Common Stock (the “Option Warrants” and, collectively with the Option Shares, the “Option Securities”) ), which may be purchased in any combination of Option Shares and/or Option Warrants at the Share Purchase Price and/or Warrant Purchase Price, respectively.

Appears in 1 contract

Samples: Underwriting Agreement (Zosano Pharma Corp)

Option to Purchase Additional Securities. (a) For the purposes of covering any over-allotments in connection with the distribution and sale of the Closing Securities, the Representative is hereby granted an option (the “Option”) to purchase, in the aggregate, up to 1,470,000 3,939,962 shares of Common Stock (the “Option Shares”) and and/or up to 3,939,962 Warrants to purchase up to 2,940,000 1,969,981 shares of Common Stock (the “Option Warrants” and, collectively with the Option Shares, the “Option Securities”) which may be purchased in any combination of Option Shares and/or Option Warrants at the Share Purchase Price and/or Warrant Purchase Price, respectively.

Appears in 1 contract

Samples: Underwriting Agreement (Oncocyte Corp)

Option to Purchase Additional Securities. (a) For the purposes of covering any over-allotments in connection with the distribution and sale of the Closing Securities, the Representative is hereby granted an option (the “Option”) to purchase, in the aggregate, up to 1,470,000 shares of Common Stock 391,273 ADSs (the “Option Shares”) and ), Series E Warrants to purchase up to 2,940,000 shares of Common Stock 391,273 ADSs and Series F Warrants to purchase up to 391,273 ADSs (such Series E and Series F Warrants, the “Option Warrants” and, collectively with the Option Shares, the “Option Securities”) which may be purchased in any combination of Option Shares and/or Option Warrants at the Share Purchase Price and/or Series E and/or Series F Warrant Purchase Price, respectively.

Appears in 1 contract

Samples: Underwriting Agreement (Biodexa Pharmaceuticals PLC)

Option to Purchase Additional Securities. (a) For the purposes of covering any over-allotments in connection with the distribution and sale of the Closing Securities, the Representative is hereby granted an option (the "Option") to purchase, in the aggregate, up to 1,470,000 75,000 shares of Common Stock Shares (the "Option Shares") and Common Warrants to purchase up to 2,940,000 75,000 shares of Common Stock Shares (the "Option Warrants", and, collectively with the Option Shares, the "Option Securities") which may be purchased in any combination of Option Shares and/or Option Warrants at the Share Purchase Price and/or Warrant Purchase Priceprice, respectively.

Appears in 1 contract

Samples: GREENPOWER MOTOR Co INC.

Option to Purchase Additional Securities. (a) For the purposes of covering any over-allotments in connection with the distribution and sale of the Closing Securities, the Representative is hereby granted an option (the “Option”) to purchase, in the aggregate, up to 1,470,000 586,956 shares of Common Stock (the “Option Shares”) and Warrants to purchase up to 2,940,000 293,478 shares of Common Stock (the “Option Warrants” and, collectively with the Option Shares, the “Option Securities”) which may be purchased in any combination of Option Shares and/or Option Warrants at the Share Purchase Price and/or Warrant Purchase Price, respectively.

Appears in 1 contract

Samples: Mawson Infrastructure Group Inc.

AutoNDA by SimpleDocs

Option to Purchase Additional Securities. (a) For the purposes of covering any over-allotments in connection with the distribution and sale of the Closing Securities, the Representative is hereby granted an option (the “Option”) to purchase, in the aggregate, up to 1,470,000 1,090,909 shares of Common Stock (the “Option Shares”) and ), Series E Warrants to purchase up to 2,940,000 1,090,909 shares of Common Stock and Series F Warrants to purchase up to 1,090,909 shares of Common Stock (the “Option Warrants” and, collectively with the Option Shares, the “Option Securities”) which may be purchased in any combination of Option Shares and/or Option Warrants at the Share Purchase Price and/or Warrant Purchase Price, respectively.

Appears in 1 contract

Samples: Underwriting Agreement (Intelligent Bio Solutions Inc.)

Option to Purchase Additional Securities. (a) For the purposes of covering any over-allotments in connection with the distribution and sale of the Closing Securities, the Representative is hereby granted an option (the “Option”) to purchase, in the aggregate, up to 1,470,000 750,000 shares of Common Stock (the “Option Shares”) and ), Series A Warrants to purchase up to 2,940,000 750,000 shares of Common Stock and Series B Warrants to purchase up to 750,000 shares of Common Stock (the “Option Warrants” and, collectively with the Option Shares, the “Option Securities”) which may be purchased in any combination of Option Shares and/or Option Warrants at the Share Purchase Price and/or Warrant Purchase Price, respectively.

Appears in 1 contract

Samples: Underwriting Agreement (NeuroBo Pharmaceuticals, Inc.)

Option to Purchase Additional Securities. (a) For the purposes of covering any over-allotments in connection with the distribution and sale of the Closing Securities, the Representative is hereby granted an option (the “Option”) to purchase, in the aggregate, up to 1,470,000 750,000 shares of Common Stock (the “Option Shares”) and ), Class C Warrants to purchase up to 2,940,000 750,000 shares of Common Stock and Class D Warrants to purchase up to 750,000 shares of Common Stock and (the “Option Warrants” and, collectively with the Option Shares, the “Option Securities”) which may be purchased in any combination of Option Shares and/or Option Warrants at the Share Purchase Price and/or Warrant Purchase Price, respectively.

Appears in 1 contract

Samples: Underwriting Agreement (Kiora Pharmaceuticals Inc)

Option to Purchase Additional Securities. (a) For the purposes of covering any over-allotments in connection with the distribution and sale of the Closing Securities, the Representative is hereby granted an option (the “Option”) to purchase, in the aggregate, up to 1,470,000 581,250 shares of Common Stock (the “Option Shares”) and Warrants to purchase up to 2,940,000 581,250 shares of Common Stock (the “Option Warrants” and, collectively with the Option Shares, the “Option Securities”) which may be purchased in any combination of Option Shares and/or Option Warrants at the Share Purchase Price and/or Warrant Purchase Price, respectively.

Appears in 1 contract

Samples: Underwriting Agreement (Creative Medical Technology Holdings, Inc.)

Option to Purchase Additional Securities. (a) For the purposes of covering any over-allotments in connection with the distribution and sale of the Closing Securities, the Representative is hereby granted an option (the “Option”) to purchase, in the aggregate, up to 1,470,000 3,925,525 shares of Common Stock (the “Option Shares”) and ), Class A Warrants to purchase up to 2,940,000 3,925,525 shares of Common Stock and Class B Warrants to purchase up to 3,925,525 shares of Common Stock (the “Option Warrants” and, collectively with the Option Shares, the “Option Securities”) which may be purchased in any combination of Option Shares and/or Option Warrants at the Share Purchase Price and/or Warrant Purchase Price, respectively.

Appears in 1 contract

Samples: Underwriting Agreement (Kiora Pharmaceuticals Inc)

Option to Purchase Additional Securities. (a) For the purposes of covering any over-allotments in connection with the distribution and sale of the Closing Securities, the Representative is hereby granted an option (the “Option”) to purchase, in the aggregate, up to 1,470,000 191,250 shares of Common Stock (the “Option Shares”) and up to 191,250 Warrants to purchase up to 2,940,000 an aggregate of 286,875 shares of Common Stock (the “Option Warrants” and, collectively with the Option Shares, the “Option Securities”) which may be purchased in any combination of Option Shares and/or Option Warrants at the Share Purchase Price and/or Warrant Purchase Price, respectively.

Appears in 1 contract

Samples: Underwriting Agreement (ReShape Lifesciences Inc.)

Time is Money Join Law Insider Premium to draft better contracts faster.